IGG4-RELATED DISEASE

Clinical trials for IGG4-RELATED DISEASE explained in plain language.

Never miss a new study

Get alerted when new IGG4-RELATED DISEASE trials appear

Sign up with your email to follow new studies for IGG4-RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2 Terminated 1

Immune cells take aim at rare autoimmune disease

Disease control Not yet recruiting

This early study tests a new treatment called KN5601, which uses specially engineered natural killer (NK) cells to target and destroy immune cells that cause IgG4-related disease. The goal is to see if it is safe and can put the disease into remission without needing long-term st…

Matched conditions: IGG4-RELATED DISEASE

Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control

Last updated May 14, 2026 12:05 UTC

IGG4-RELATED DISEASE

Get alerted when new IGG4-RELATED DISEASE trials appear

Immune cells take aim at rare autoimmune disease